Reply to Shapiro, "Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing
Enterobacterales
"
Antimicrob Agents Chemother
.
2022 May 17;66(5):e0035322.
doi: 10.1128/aac.00353-22.
Epub 2022 Apr 26.
Authors
Juan Carlos Vázquez-Ucha
1
,
Cristina Lasarte-Monterrubio
1
,
Paula Guijarro-Sánchez
1
,
Marina Oviaño
1
,
Laura Álvarez-Fraga
1
,
Isaac Alonso-García
1
,
Jorge Arca-Suárez
1
,
German Bou
1
,
Alejandro Beceiro
1
Affiliation
1
Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Coruña, CIBER de Enfermedades Infecciosas, Spain.
PMID:
35471039
PMCID:
PMC9112983
DOI:
10.1128/aac.00353-22
No abstract available
Publication types
Letter
Comment
MeSH terms
Azabicyclo Compounds*
Cefepime
Triazoles*
beta-Lactamases / genetics
Substances
Azabicyclo Compounds
Triazoles
Cefepime
enmetazobactam
beta-Lactamases